The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
The pursuit of matrix metalloproteinase (MMP) inhibitors began in earnest over three decades ago.Initial clinical trials were disappointing, resulting in a Collections negative view of MMPs as therapeutic targets.As a better understanding of MMP biology and inhibitor pharmacokinetic properties emerged, it became clear that initial MMP inhibitor cli